WEE1 and chronic myelogenous leukemia, BCR-ABL1 positive: Combining the WEE1 inhibitor MK‐1775 with vitamin K2 enhanced cytotoxicity and apoptosis in Chronic myeloid leukemia(CML) cells, including TKI‐resistant strains.